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Abstract
Background  and  aims:  Spontaneous  bacterial  peritonitis  (SBP)  is  a  common  complication  of
cirrhosis.  Identiﬁcation  of  poor  prognosis  predictors  is  essential  in  disease  approach.
Methods:  Medical  records  from  patients  admitted  at  our  institution  between  January  2008  and
December 2010  with  spontaneous  bacterial  peritonitis  were  retrospectively  reviewed.  Crite-
ria assessed  were  age,  sex,  presenting  symptoms,  risk  factors,  ascitic  ﬂuid  characteristics,
evolution  during  hospitalization,  prophylaxis  at  discharge  and  re-admission.
Results:  42  (34  male,  8  female)  patients  were  included  in  the  study.  Mean  age  was  57.46  ±
13.4 years.  Abdominal  pain  was  the  most  common  presenting  symptom  (59.5%);  69%  of  patients
had Child-Pugh  C.  7.1%  have  had  previous  episodes  of  spontaneous  bacterial  peritonitis,  but
only 2.4%  were  on  antibiotic  prophylaxis.  71.4%  of  ﬁrst  paracentesis  were  culture-negative.  In
the remaining,  Escherichia  coli  (16.7%)  was  the  agent  most  frequently  isolated.  32.25%  patients
who started  treatment  with  Ceftriaxone,  were  switched  to  another  antibiotic.  Average  length
of hospitalization  was  16.10  ±  12  days.  Mortality  rate  was  28.6%.  Of  the  variables  analyzed
with the  methodology  of  Cox,  hepatorenal  syndrome  (HR  =  29.92,  p  <  0.001)  and  septic  shock
(HR =  9.5,  p  =  0.001)  were  signiﬁcantly  associated  with  higher  mortality  risk,  with  renal  failure
being suggestively  associated  (HR  =  3.25,  p  =  0.063).  Of  the  71.4%  patients  discharged,  46.67%
were on  prophylaxis  with  21.42%  of  them  being  re-admitted  with  the  same  diagnosis,  while
31.25% discharged  without  prophylaxis  were  re-admitted  (p  =  0.36).
Conclusion: The mortality  is  elevated,  with  hepatorenal  syndrome  and  septic  shock  being  poten-
tial predictors  of  mortality.  Ceftriaxone  fails  in  a  high  percentage  of  SBP  episodes  and  may  not
be the  most  appropriate  ﬁrst-line  treatment.
© 2011  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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Síndrome  hepatorrenal,  choque  sético  e  insuﬁciência  renal  como  preditores
de  mortalidade  em  doentes  com  peritonite  bacteriana  espontânea
Resumo
Introduc¸ão  &  objetivos:  A  peritonite  bacteriana  espontânea  (PBE)  é  uma  complicac¸ão  comum
em doentes  cirróticos.  A  identiﬁcac¸ão  de  fatores  preditivos  de  mau  prognóstico  é  essencial  na
abordagem  desta  patologia.
Métodos: Foram  analisados  retrospetivamente  os  processos  clínicos  dos  doentes  internados  na
nossa instituic¸ão  entre  janeiro  de  2008  e  dezembro  de  2009  com  o  diagnóstico  de  PBE.  Os
critérios avaliados  foram  idade,  sexo,  sintomas  de  apresentac¸ão,  fatores  de  risco,  caracterís-
ticas do  líquido  ascítico,  evoluc¸ão  no  internamento,  medicac¸ão  proﬁlática  aquando  da  alta  e
reinternamento.
Resultados:  Foram  incluídos  42  doentes  no  estudo  (34  do  sexo  masculino  e  8  do  sexo  femi-
nino). A  idade  média  no  internamento  foi  57,46  ±  13,4  anos.  A  dor  abdominal  foi  o  sintoma
de apresentac¸ão  mais  comum  (59,5%);  69%  dos  doentes  tinham  Child-Pugh  C.  7,1%  já  tinham
tido episódios  prévios  de  peritonite  bacteriana  espontânea,  mas  apenas  2,4%  fazia  proﬁlaxia
antibiótica  à  admissão.  Não  se  isolou  qualquer  agente  em  71,4%  dos  doentes;  nos  restantes,
a E.  coli  foi  o  agente  mais  frequente  (16,7%).  32,25%  dos  doentes  que  iniciaram  antibioter-
apia empírica  com  ceftriaxone  tiveram  que  alterar  para  outro  antibiótico  com  maior  espetro
de ac¸ão.  A  durac¸ão  média  do  internamento  foi  de  16,10  ±  12  dias.  A  taxa  de  mortalidade  foi
de 28,6%.  Das  variáveis  analisadas  com  a  metodologia  de  Cox,  estão  signiﬁcativamente  asso-
ciadas a  risco  de  mortalidade  mais  elevado  o  síndrome  hepatorrenal  (HR  =  29,92;  p<0,001),  o
choque sético  (HR  =  9,5;  p  =  0,001)  e  sugestivamente  a  insuﬁciência  renal  (HR  =  3,25;  p  =  0,063).
Dos 71,4%  doentes  que  tiveram  alta,  46,67%  foram  medicados  proﬁlaticamente,  com  21,42%
a serem  reinternados  com  o  mesmo  diagnóstico,  sendo  que  apenas  31,25%  dos  doentes  que
tiveram alta  sem  proﬁlaxia  foram  reinternados  (p  =  0,36).
Conclusão:  A  mortalidade  é  elevada,  sendo  a  presenc¸a  de  síndrome  hepatorrenal  e  choque
sético potenciais  preditores  de  risco  de  morte.  O  ceftriaxone  pode  não  ser  o  antibiótico  empírico
de primeira  linha  mais  adequado,  tendo  em  conta  a  falência  terapêutica  numa  percentagem
elevada  de  doentes.
©  2011  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos reservados.
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aIntroduction
Spontaneous  bacterial  peritonitis  (SBP)  is  a  common  and
severe  complication  in  patients  with  advanced  cirrhosis.  It
is  deﬁned  as  an  ascitic  ﬂuid  infection  without  an  evident
intra-abdominal  cause.  When  ﬁrst  described,  its  mortality
rate  exceeded  90%  but  with  early  diagnosis  and  treatment
it  is  now  reduced  to  about  20%.1,2
The  diagnosis  of  SBP  is  established  with  a  diagnostic
paracentesis.3 All  patients  with  cirrhosis  and  ascites  are  at
risk  of  SBP;  its  prevalence  is  higher  in  hospitalized  patients
(10%  versus  1.3--3.5%).4 Half  of  the  patients  are  diagnosed
with  SBP  at  hospital  admission  and  the  rest  consist  in  noso-
comial  infections.
Ascites  culture  is  negative  in  as  many  as  60%  of  patients
with  clinical  manifestations  suggestive  of  SBP  and  increased
ascites  neutrophil  count.3,5 For  SBP  diagnosis,  the  number
of  polymorphonuclear  leucocytes  in  the  ascitic  ﬂuid  must
exceed  250  cells/mm3 and  bacteriological  cultures  must  be
positive.3,6 Patients  with  an  ascitic  ﬂuid  neutrophil  count
>250  cells/mm3 and  negative  culture  have  culture-negative
SBP.  Their  clinical  presentation  is  similar  to  that  of  patients
with  culture-positive  SBP  and  should  be  given  the  same
treatment.3,6 Some  patients  have  bacterascites  in  which
cultures  are  positive  but  ascitic  ﬂuid  neutrophil  count  is
c
c
i250/mm3.3,6 Bacterascites  may  result  from  secondary
acterial  colonization  of  ascites  from  an  extraperitoneal
nfection  or  from  spontaneous  colonization  of  ascites,
nd  it  can  be  a  transient  and  spontaneously  reversible
olonization  of  ascites,  or  may  represent  the  ﬁrst  step  in
he  development  of  SBP.
The  most  common  pathogens  involved  are  Gram-negative
acteria  (60%),  usually  Escherichia  coli  or  Klebsiella
neumonia.3,6,7 In  about  25%  of  the  cases,  Gram-positive
acteria  are  involved,  mainly  Streptococcus  species  and
nterococci.7,8 This  is  manly  due  to  the  prophylaxis  with
uinolones,  used  to  reduce  the  incidence  of  SBP  episodes.9
lthough  the  bowel  ﬂora  is  predominantly  anaerobic,  these
icroorganisms  rarely  cause  SBP.7 The  epidemiology  of
acterial  infections  differs  between  community-acquired
in  which  Gram  negative  infections  predominate)  and
osocomial  infections  (in  which  Gram-positive  infections
redominate).6
The  clinical  presentation  in  SBP  is  non-speciﬁc.  Patients,
articularly  outpatients,  may  be  asymptomatic.  Other  signs
nd  symptoms  associated  include  fever,  abdominal  pain,
hills,  nausea  or  vomiting,  ileus,  diarrhea,  mental  status
hanges  and  renal  impairment.
Antibiotics  should  be  started  at  diagnosis  and  adjusted,
f  necessary,  according  with  the  ascitic  ﬂuid  cultural  results.
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Table  1  Overall  basal  characteristics  of  the  patients.
Characteristic  Value  (n  =  42)
Gender  (M/F) 34/8
Age  (mean  ±  SD) 57.46  ±  13.4  years
Child-Pugh  class
Class  A  1  (2.4%)
Class B  12  (28.6%)
Class C  29  (69%)
Symptoms  at  presentation
Fever  14  (33.3%)
Abdominal  pain  25  (59.5%)
Changes  in  gut  motility  14  (33.3%)
Changes  in  mental  status  17  (40.5%)
SBP diagnosis
At  admission  35  (83.3%)
During  hospitalization  4  (9.5%)
Without  criteria 3  (7.1%)
Hospitalization  length 16.10  ±  12.01  days
-
-
-
w
t
d
(
e
T
m
f
b
w
t
a
C
a
P
R
F
c
n
s80  
onsidering  Gram-negative  bacteria  are  the  most  frequent
athogens  involved,  the  ﬁrst  line  antibiotic  treatment
hould  be  third-generation  cephalosporin’s.10--12 Alternative
ptions  include  amoxycillin/clavulanic  acid,  quinolones  and
iperacilin/tazobactam.  SBP  resolves  with  antibiotic  ther-
py  in  approximately  90%  of  patients.  A  second  paracentesis,
8  h  after  the  beginning  of  antibiotic  therapy,  should  be
ade  to  assess  a  decline  in  the  neutrophil  count,  when
o  clinical  improvement  occurs  or  when  the  initial  ascitic
uid  analysis  revealed  atypical  ﬁndings.11 Failure  of  antibi-
tic  therapy  is  usually  due  to  resistant  bacteria  or  secondary
acterial  peritonitis.
Certain  subgroups  of  patients  with  cirrhosis  and  ascites
ave  a  higher  risk  of  developing  SBP  and  should  be
n  a  prophylaxis  antibiotic  regimen.  The  use  of  pro-
hylactic  antibiotics  is  approved  in  patients  with  acute
astrointestinal  hemorrhage,  patients  with  low  total  protein
oncentration  in  ascitic  ﬂuid  (and  no  prior  history  of  SBP)  and
atients  with  a  previous  history  of  SBP.7 Newer  quinolones
re  the  prophylactic  antibiotics  of  choice  because  they  not
nly  eliminate  aerobic  Gram-negative  bacteria  from  the
ntestinal  ﬂora  but  also  appear  to  have  an  immunoreg-
latory  part  by  stimulating  the  bactericidal  capacity  of
olymorphonuclear  cells  and  decreasing  bacterial  adhesion
o  mucosal  surfaces.11
Approximately  half  of  all  deaths  in  patients  with  SBP
ccur  after  the  resolution  of  the  infection  and  are  usu-
lly  the  result  of  gastrointestinal  hemorrhage,  liver  or  renal
ailure.  The  presence  of  renal  failure  is  the  strongest  inde-
endent  prognostic  indicator,  but  the  presence  of  peripheral
eukocytosis,  advanced  age,  higher  Child-Pugh  score  and
leus  have  also  shown  to  predict  inpatient  mortality.13--19
atients  with  nosocomial  versus  community-acquired  SBP
ppear  to  have  a  higher  mortality.  The  existence  of  a  pos-
tive  ascitic  ﬂuid  culture  or  bacteremia  does  not  seem  to
nﬂuence  prognosis.13
The  aim  of  this  study  was  to  characterize  a  consecutive
eries  of  patients  with  SBP  diagnosis,  regarding  risk  factors,
omplications  during  hospitalization  and  their  inﬂuence  in
rognostic.
ethods
edical  records  from  patients  admitted  between  January
008  and  December  2009  with  the  diagnosis  of  SBP  (either
t  admission  or  during  hospitalization)  were  reviewed.  The
riteria  assessed  were:
 Patients’  age  and  gender;
Symptoms  at  presentation  (as  fever,  abdominal  pain,
changes  in  gut  motility  and  mental  status);
Risk  factors  for  SBP  (severity  of  liver  disease  according  to
Child-Pugh’s  classiﬁcation,  prior  episodes  of  SBP,  presence
of  esophageal  varices,  use  of  proton  pump  inhibitors,  if  on
an  antibiotic  prophylactic  regimen,  total  serum  bilirubin
concentration  >2.5  mg/dL,  plasma  creatinine  ≥1.2  mg/dL,
plasma  sodium  ≤130  mEq/L);
Characteristics  of  the  ascitic  ﬂuid  (cytochemical  SBP
criteria,  ascitic  ﬂuid  culture,  ascitic  ﬂuid  total  protein
concentration  <1.5  g/dL);
m
t
iMortality 12  (28.6%)
SBP, spontaneous bacterial peritonitis.
 Clinical  evolution  (if  complicated  by  septic  shock,  hep-
atorenal  syndrome,  renal  failure  or  other  infections  and
length  of  hospitalization);
 Antibiotic  therapy  (if  discharged  on  a  prophylactic  regi-
men);
 Re-admissions  with  the  same  diagnosis  (the  clinical
records  used  here  where  the  ones  from  the  ﬁrst  admis-
sion).
Patients  without  cirrhosis  and  presenting  with  ascites
ere  excluded.  When  the  end  point  evaluated  was  death,
he  period  ranging  from  date  of  hospitalization  admission  to
ate  of  death  was  considered  the  survival  period.
Data  were  analyzed  using  a  statistical  software  program
SPSS  18).  Results  were  expressed  as  mean  ±  SD.  The  differ-
nces  between  groups  were  determined  by  Student’s  t  test.
he  chi-square  test  was  used,  when  appropriate,  to  deter-
ine  the  differences  in  proportions.  The  independent  role  of
actors  selected  by  univariate  analysis  was  further  assessed
y  stepwise  regression  analysis.  Kaplan--Meier  methodology
as  performed  to  analyze  the  survival  of  patients  within
he  different  groups.  The  log  rank  test  was  used  to  evalu-
te  the  statistical  differences  between  survival  curves.  The
ox  regression  analysis  was  performed  to  analyze  the  Haz-
rd  risk.  The  statistical  signiﬁcance  was  established  at  a
 value  of  less  than  0.05.
esults
or  interpretative  purposes,  patients  with  polymorphonu-
lear  leucocytes  ≥250  cells/mm3,  either  culture  positive  or
egative,  with  similar  clinical  presentations  and  treated  the
ame  way,  will  both  be  considered  as  having  SBP.Of  the  42  patients  with  SBP  (see  Table  1),  34  (81%)  were
ale  and  8  (19%)  were  female.  SBP  was  diagnosed  at  hospi-
al  admission  in  35  (83.3%)  patients,  in  4  of  the  patients
nfections  were  nosocomial  and  the  other  (n  =  3)  did  not
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Table  2  Presentation  of  risk  factors  for  SBP.
Risk  factors Value  (n  =  42)
SBP  previous  episodes 3 (7.1%)
On prophylaxis  1  (2.4%)
Varices
No 17  (40.5%)
Yes, without  hemorrhage  17  (40.5%)
Yes, with  hemorrhage  8  (19%)
On PPIs  12  (28.6%)
Bilirrubin  ≥2.5  mg/dL  25  (59.5%)
Creatinine  ≥1.2  mg/dL 21 (50%)
Sodium  <130  mEq/L 13 (31%)
Total  proteins  <1.5  g/dL  23  (54.8%)
Table  3  Results  from  ascitic  ﬂuid  culture.
Etiologic  agent  Value  (n  =  42)
Culture  negative  30  (71.4%)
Escherichia  Coli  7  (16.7%)
Citrobacter  freundii  1  (2.4%)
Listeria  monocytogenis  1  (2.4%)
Streptococcus  salivarius  1  (2.4%)
Table  4  Type  of  antibiotic  therapy.
Antibiotic  Value  (n  =  42)
Ceftriaxone 31  (73.8%)
Piperacilin/Tazobactam 1 (2.38%)
Levoﬂoxacin 1 (2.38%)
Ciproﬂoxacin  3  (7.14%)
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ence  between  survival  curves  was  statistically  signiﬁcant
(p  <  0.001;  log  rank  test)  (see  Fig.  3).
Table  5  Odds  ratio  and  hazard  ratio  for  complications.
Evolution  Cox  regression
Death  (n  =  12)  No  death  (n  =  30)  HR  p
Renal  failure
Yes  7  4  3.25  0.063
No 5  23
Septic  shock
Yes  8  1  9.5  0.001
No 4  27
Hepatorenal  syndromeWithout  culture  exam  2  (4.8%)
meet  the  diagnostic  criteria.  The  mean  age  at  admission  was
57.46  ±  13.4  years  (range  36--84),  with  women  being  older
(63.13  ±  11.29  years)  (p  =  0.185)  than  men.
Abdominal  pain,  present  in  25  (59.5%)  patients,  was  the
most  common  symptom,  followed  by  mental  status  alter-
ations  (n  =  17;  40.5%),  fever  (n  =  14;  33.3%)  and  changes  in
gut  motility  (n  =  14;  33.3%).
Twenty  nine  patients  (69%)  were  classiﬁed  as  Child-Pugh
C,  12  (28.6%)  as  Child-Pugh  B  and  only  one  (2.4%)  patient  was
classiﬁed  as  Child-Pugh  A.  Three  patients  (7.1%)  were  pre-
viously  diagnosed  with  SBP,  but  only  one  of  them  (2.4%)  was
on  antibiotic  prophylaxis  at  admission.  Seventeen  patients
(40.5%)  did  not  have  esophageal  varices,  and  25  (59.5%)  had
varices  (8  [19%]  with  hemorrhage  and  17  [40.5%]  without).  At
hospital  admission  12  patients  (28.6%)  were  on  proton  pump
inhibitors,  25  (59.5%)  had  total  serum  bilirubin  ≥2.5  mg/dL,
21  (50%)  had  plasma  creatinine  ≥1.2  mg/dL  and  13  (31%)  had
plasma  sodium  ≤130  mEq/L  (see  Table  2).  Total  serum  biliru-
bin,  plasma  creatinine,  plasma  sodium  and  the  presence  of
esophageal  varices  did  not  show  a  statistically  signiﬁcant
association  with  a  higher  mortality  risk.
Regarding  the  ﬁrst  paracentesis  done  during  hospital-
ization,  71.4%  (n  =  30)  of  the  ascitic  ﬂuids  analyzed  were
culture-negative  and  4.8%  (n  =  2),  despite  having  cytochem-
ical  SBP  criteria,  were  not  submitted  to  bacteriological
testing.  Escherichia  coli  (n  =  7;  16.7%)  was  the  pathogen
most  frequently  isolated,  with  Citrobacter  freundii,  Listeria
monocytogenis  and  Streptococcus  salivarius  being  isolated
once  each  (see  Table  3).  Twenty  three  (54.8%)  patients
had  ascitic  ﬂuid  total  protein  concentration  <1.5  g/dL  at
admission;  survival  in  these  patients,  however,  was  not
statistically  different  from  those  with  higher  protein  concen-
tration  (p  =  0.612;  log  rank  test).No information  6  (14.28%)
Thirty  one  (73.8%)  patients  were  treated  with  Ceftria-
one,  three  (7.14%)  with  Ciproﬂoxacin,  one  (2.38%)  with
iperacilin/Tazobactam  and  one  (2.38%)  with  Levoﬂoxacin;
here  was  no  information  regarding  the  antibiotic  regimen
sed  in  the  clinical  records  of  six  (14.28%)  patients.  Of  those
n  Ceftriaxone,  10  (32.25%)  did  not  respond  to  the  treatment
nd  were  switched  to  another  antibiotic  (see  Table  4).
Of  the  21  (50%)  patients  who  repeated  paracentesis  dur-
ng  hospitalization,  19  (45.2%)  had  culture-negative  ascitic
uid,  one  (2.4%)  was  positive  for  Escherichia  coli  and  one
2.4%)  for  Enterococcus  faecalis  plus  Aeromonas  hydophila.
The  average  length  of  hospitalization  was  16.10  ±
2.01  days,  with  men  having  a  longer  length  stay
17.21  ±  12.65  days)  than  women  (11.38  ±  7.70  days).  Yet,
his  difference  was  not  statistically  signiﬁcant  (p  =  0.221).
Regarding  complications  (see  Table  5)  registered  dur-
ng  hospitalization,  the  presence  of  renal  failure  (RF)  was
ssociated  with  a  higher  mortality  risk  (OR  =  8.1;  p  =  0.005;
hi-square  test),  which  is  re-enforced  by  using  the  Cox
egression  (HR  =  3.25;  p  =  0.063),  suggesting  a  3  times  higher
isk  of  death  in  these  patients;  there  is  statistical  signiﬁ-
ance  (p  =  0.045;  log  rank  test)  when  comparing  the  survival
urves  regarding  the  presence  or  absence  of  RF  (see  Fig.  1).
he  presence  of  septic  shock  was  also  associated  with  a
igher  mortality  risk  (OR  =  54;  p  <  0.001;  chi-square  test),
ith  a  9  times  higher  risk  of  death  (HR  =  9.5;  p  =  0.001;  Cox
egression);  the  difference  between  survival  curves  was  sta-
istically  signiﬁcant  (p  <  0.001;  log  rank  test)  (see  Fig.  2).
Hepatorenal  syndrome  was  the  complication  associated
ith  the  higher  mortality  risk,  a  29  times  higher  risk  of
eath  (HR  =  29.92;  p  <  0.001;  Cox  regression);  the  differ-Yes 4  0  29.92  <  0.001
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Figure  1  Kaplan--Meier  analysis  of  the  cumulative  survival
according  to  presence  of  renal  failure.
1.0
0.8
0.6
0.4
Cu
m
m
ul
at
ive
 s
ur
viv
al
0.2
0.0
0 10 20 30
Septic shock
p<0.001; log rank test
Without septic shock
Length of hospitalization
40 50
++++++++ ++
++
++++ ++
+
Figure  2  Kaplan--Meier  analysis  of  the  cumulative  survival
according  to  presence  of  septic  shock.
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Figure  3  Kaplan--Meier  analysis  of  the  cumulative  survival
according  to  presence  of  hepatorenal  syndrome.
Table  6  Prophylaxis  on  discharge  and  re-admission.
Prophylaxis  Value  (n  =  30)
Yes 14  (46.67%)
Re-admission 3 (21.42%)
No 16 (53.33%)
Re-admission  5  (31.25%)
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bFigure  4  Re-admission  regarding  prophylaxis.
Of  the  30  (71.4%)  patients  discharged  from  the  hospital,
4  (46.67%)  were  on  antibiotic  prophylaxis,  with  3  (21.42%)
f  them  being  later  re-admitted  with  the  same  diagnosis;  of
he  16  (31.25%)  patients  discharged  without  prophylaxis,  5
ere  re-admitted.  However,  no  statistically  signiﬁcant  dif-
erence  was  found  between  the  two  groups  (p  =  0.36)  (see
able  6  and  Fig.  4).
iscussion
BP  is  a  common  complication  in  patients  with  cirrhosis-
elated  ascites.  With  an  insidious  and  subtle  installation,  it’s
iagnosis,  based  on  ascitic  ﬂuid  cytochemical  and  bacterio-
ogical  analysis,  requires  a  high  suspicion  index.13
The  aim  of  this  study  was  to  evaluate,  in  patients  admit-
ed  with  SBP  diagnosis,  the  risk  factors  accepted  in  the
iterature  as  a  cause  for  the  disease  and  which  of  them
nﬂuenced  it’s  prognosis.
In our  series,  only  three  of  the  patients  had  previous  SBP
iagnosis,  with  one  of  them  being  on  a prophylaxis  antibiotic
egimen.  For  this  reason,  it  was  not  possible  to  assess  the
ffect  of  prophylaxis  in  survival.
Most  patients  were  in  an  advanced  phase  of  the  dis-
ase  (Child-Pugh  C).  Abdominal  pain  was  the  most  frequent
ymptom  at  admission,  although  in  other  studies  published
ever  was  the  most  common  symptom  reported.12 However,
bdominal  pain  can  be  the  result  of  the  distension  caused
y  the  ascitic  ﬂuid.
erit
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1Mortality  predictors  in  patients  with  spontaneous  bacterial  p
Total  serum  bilirubin  concentration,  plasma  creatinine
and  plasma  sodium  levels  did  not  alter  the  risk  of  death  in
a  statistically  signiﬁcant  way.  In  this  study  we  retrospectiv-
elly  examined  the  presence  of  complications  in  association
with  bilirubin,  creatinine  and  sodium  levels.  Further  studies
must  include  the  assessment  of  the  effect  of  these  variables
in  the  risk  of  developing  complications.
The  presence  of  hepatorenal  syndrome  and  septic  shock
inﬂuenced  the  outcome,  with  those  patients  with  hepatore-
nal  syndrome  having  a  twenty-nine  times  higher  risk  of  death
and  those  with  septic  shock  having  a  nine  times  higher  risk.
Renal  failure  was  also  suggestively  associated  with  death.
We  might  say  that  the  presence  of  hepatorenal  syndrome
and  septic  shock  are  potential  predictors  of  mortality  risk.
Ceftriaxone,  suggested  as  the  ﬁrst  line  empiric  antibiotic
treatment,  failed  in  more  than  30%  of  SBP  episodes.  This  is
further  supported  by  the  ﬁndings  of  Angeloni  et  al.9 One  may
infer  that  it  might  be  related  with  either  the  appearance  of
antibiotic  resistances  or  with  changes  in  etiologic  agents.
These  results  should  promote  further  investigation  aimed  at
identifying  different  treatment  approaches.
Despite  the  latest  guidelines  that  support  the  use  of
antibiotic  prophylaxis  in  all  patients  with  SBP  after  hospi-
tal  discharge,20 in  our  study  only  46.67%  of  the  patients
included  were  on  prophylaxis.  Nevertheless,  re-admissions
in  this  sub-group  were  not  statistically  signiﬁcantly  different
from  those  not  on  prophylaxis.  It  is  possible  that  no  signiﬁ-
cance  was  found  owing  to  a  lack  of  statistical  power  based
on  the  small  number  of  patients  included  in  the  study.
It  was  not  possible  to  evaluate  in  this  study  if  SBP  patients
on  proton  pump  inhibitors  had  a  higher  rate  of  SBP  than  those
who  were  not.  In  further  studies  this  should  be  assessed.
The  fact  that  the  study  was  retrospective,  made  it  more
difﬁcult  to  analyze  certain  variables,  as  data  was  missing  in
some  patients  ﬁles.  Patient  search  and  selection  was  limited
to  patients  with  SBP  diagnosis,  based  on  the  CDI-10  classiﬁ-
cation,  by  the  time  of  discharge  or  death.  There  might  have
been  more  patients  in  whom  this  diagnosis  was  not  done  or
who  were  not  correctly  codiﬁed.
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